High mitochondria content is associated with prostate cancer disease progression

by Grupp, Katharina, Jedrzejewska, Karolina, Tsourlakis, Maria Christina, Koop, Christina, Wilczak, Waldemar, Adam, Meike, Quaas, Alexander, Sauter, Guido, Simon, Ronald, Izbicki, Jakob Robert, Graefen, Markus, Huland, Hartwig, Schlomm, Thorsten, Minner, Sarah, Steurer, Stefan
Published 2013

High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

by Melling, Nathaniel, Harutyunyan, Levon, Hube-Magg, Claudia, Kluth, Martina, Simon, Ronald, Lebok, Patrick, Minner, Sarah, Tsourlakis, Maria Christina, Koop, Christina, Graefen, Markus, Adam, Meike, Haese, Alexander, Wittmer, Corinna, Steurer, Stefan, Izbicki, Jakob, Sauter, Guido, Wilczak, Waldemar, Schlomm, Thorsten, Krech, Till
Published 2015

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

by Zabalza, Cristina Villares, Adam, Meike, Burdelski, Christoph, Wilczak, Waldemar, Wittmer, Corina, Kraft, Stefan, Krech, Till, Steurer, Stefan, Koop, Christina, Hube-Magg, Claudia, Graefen, Markus, Heinzer, Hans, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten, Tsourlakis, Maria Christina
Published 2015

Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer

by Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
Published 2015